Compile Data Set for Download or QSAR
maximum 50k data
Found 2915 with Last Name = 'gibson' and Initial = 'k'
LigandPNGBDBM144227(US8952008, 4)
Affinity DataKi:  0.180nMAssay Description:Displacement of [3H]-flumazenil from human GABAA alpha1beta3gamma2 receptor expressed in HEK293 cell membranes measured after 2 hrs by liquid scintil...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50142577(11-(4-Chloro-phenyl)-9-(4-methyl-thiazol-2-yl)-6,7...)
Affinity DataKi:  0.200nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha3-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGamma-aminobutyric acid receptor subunit alpha-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50142567(9-(4-Methyl-thiazol-2-yl)-11-phenyl-6,7-dihydro-5H...)
Affinity DataKi:  0.300nMAssay Description:Displacement of [3H]-Ro-15-1788 from human GABA-A receptor alpha2 subunit expressed in L(tk) cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50142577(11-(4-Chloro-phenyl)-9-(4-methyl-thiazol-2-yl)-6,7...)
Affinity DataKi:  0.400nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha1-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50142567(9-(4-Methyl-thiazol-2-yl)-11-phenyl-6,7-dihydro-5H...)
Affinity DataKi:  0.400nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha1-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604064(US11660293, Example 171 | US11660293, Example 173)
Affinity DataKi:  0.437nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50142570(9-(4-Methyl-thiazol-2-yl)-11-pyridin-4-yl-6,7-dihy...)
Affinity DataKi:  0.5nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha3-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50512947(CHEMBL4545044)
Affinity DataKi:  0.640nMAssay Description:Displacement of [3H]-flumazenil from human GABAA alpha1beta3gamma2 receptor expressed in HEK293 cell membranes measured after 2 hrs by liquid scintil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM50142567(9-(4-Methyl-thiazol-2-yl)-11-phenyl-6,7-dihydro-5H...)
Affinity DataKi:  0.700nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha1-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603987(US11660293, Example 61)
Affinity DataKi:  0.759nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604048(US11660293, Example 152 | US11660293, Example 154)
Affinity DataKi:  0.871nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604115(US11660293, Example 234 | US11660293, Example 236)
Affinity DataKi:  1.02nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM144227(US8952008, 4)
Affinity DataKi:  1.10nMAssay Description:Displacement of [3H]-flumazenil from human GABAA alpha3beta3gamma2 receptor expressed in HEK293 cell membranes measured after 2 hrs by liquid scintil...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604067(US11660293, Example 175 | US11660293, Example 177)
Affinity DataKi:  1.12nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604057(US11660293, Example 162 | US11660293, Example 164)
Affinity DataKi:  1.17nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50142563(9-(4-Methyl-thiazol-2-yl)-11-o-tolyl-6,7-dihydro-5...)
Affinity DataKi:  1.20nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha1-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604092(US11660293, Example 210 | US11660293, Example 211)
Affinity DataKi:  1.23nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604064(US11660293, Example 171 | US11660293, Example 173)
Affinity DataKi:  1.26nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM50142570(9-(4-Methyl-thiazol-2-yl)-11-pyridin-4-yl-6,7-dihy...)
Affinity DataKi:  1.30nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha1-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603991(US11660293, Example 89)
Affinity DataKi:  1.38nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604062(US11660293, Example 168 | US11660293, Example 170)
Affinity DataKi:  1.38nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604057(US11660293, Example 162 | US11660293, Example 164)
Affinity DataKi:  1.48nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM50142563(9-(4-Methyl-thiazol-2-yl)-11-o-tolyl-6,7-dihydro-5...)
Affinity DataKi:  1.5nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha3-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604066(US11660293, Example 174)
Affinity DataKi:  1.51nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604069(US11660293, Example 178 | US11660293, Example 180)
Affinity DataKi:  1.66nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604132(US11660293, Example 254 | US11660293, Example 256)
Affinity DataKi:  1.78nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604090(US11660293, Example 207 | US11660293, Example 209)
Affinity DataKi:  1.82nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603993(US11660293, Example 93)
Affinity DataKi:  1.95nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604098(US11660293, Example 218 | US11660293, Example 219)
Affinity DataKi:  1.95nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604092(US11660293, Example 210 | US11660293, Example 211)
Affinity DataKi:  2.04nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604048(US11660293, Example 152 | US11660293, Example 154)
Affinity DataKi:  2.09nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604053(US11660293, Example 158 | US11660293, Example 159 ...)
Affinity DataKi:  2.09nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50142565(9-(4-Methyl-thiazol-2-yl)-11-pyridin-3-yl-6,7-dihy...)
Affinity DataKi:  2.40nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha3-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50512947(CHEMBL4545044)
Affinity DataKi:  2.5nMAssay Description:Displacement of [3H]-flumazenil from human GABAA alpha3beta3gamma2 receptor expressed in HEK293 cell membranes measured after 2 hrs by liquid scintil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604087(US11660293, Example 203 | US11660293, Example 205)
Affinity DataKi:  2.57nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50142562(11-(1-Methyl-1H-pyrrol-2-yl)-9-(4-methyl-thiazol-2...)
Affinity DataKi:  3nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha1-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50142569(11-(2-Fluoro-phenyl)-9-(4-methyl-thiazol-2-yl)-6,7...)
Affinity DataKi:  3nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha3-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMetabotropic glutamate receptor 1(RAT)
Medical Research Council Technology

Curated by ChEMBL
LigandPNGBDBM50278288(2-(2-(4-(2,3-dihydro-1H-inden-2-ylamino)pyrido[3,4...)
Affinity DataKi:  3nMAssay Description:Antagonist activity at rat mGluR1a expressed in CHO cells assessed as inhibition of glutamate-evoked increase in calcium internalization preincubated...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604069(US11660293, Example 178 | US11660293, Example 180)
Affinity DataKi:  3.02nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604075(US11660293, Example 187 | US11660293, Example 189)
Affinity DataKi:  3.09nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50142566(4-[9-(4-Methyl-thiazol-2-yl)-8-oxo-5,6,7,8-tetrahy...)
Affinity DataKi:  3.10nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha3-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGamma-aminobutyric acid receptor subunit alpha-3/beta-3/gamma-2(Homo sapiens (Human))
The Neuroscience Research Centre

Curated by ChEMBL
LigandPNGBDBM50142561(11-(3,5-Dimethyl-isoxazol-4-yl)-9-(4-methyl-thiazo...)
Affinity DataKi:  3.10nMAssay Description:Binding affinity at human recombinant gamma-aminobutyric-acid A receptor alpha1-beta3-gamma2 expressed in L(tk) cells by [3H]-Ro-15-1788 displacement...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604011(US11660293, Example 113 | US11660293, Example 115)
Affinity DataKi:  3.16nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604005(US11660293, Example 106 | US11660293, Example 108)
Affinity DataKi:  3.24nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604090(US11660293, Example 207 | US11660293, Example 209)
Affinity DataKi:  3.47nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604103(US11660293, Example 225 | US11660293, Example 226 ...)
Affinity DataKi:  3.47nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604111(US11660293, Example 228 | US11660293, Example 230)
Affinity DataKi:  3.47nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604062(US11660293, Example 168 | US11660293, Example 170)
Affinity DataKi:  3.47nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM603992(US11660293, Example 91)
Affinity DataKi:  3.47nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Chronos Therapeutics

US Patent
LigandPNGBDBM604115(US11660293, Example 234 | US11660293, Example 236)
Affinity DataKi:  3.55nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 2915 total ) | Next | Last >>
Jump to: